Appointment of Chief Financial Officer
Quantum Pharma Plc (AIM: QP.), the growing, service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, is pleased to announce that Chris Rigg has been promoted today to the role of Chief Financial Officer, and to Quantum’s Board. His appointment follows the resignation of Martin Such, the Group’s Chief Financial Officer on 7 March 2016.
Chris joined Quantum as the Group’s Strategic Director in November 2015, since which time he has been working as part of the senior management team reporting to the Board on a broad range of Group matters.
Chris qualified as a chartered accountant at PwC and then moved to corporate finance at Deloitte for eight years. In 2009, he joined eaga Plc first as Group Corporate Finance Director and subsequently as divisional Managing Director of the Solar Division. After eaga’s acquisition by Carillion Plc in 2011, Chris joined Barclays to head its North East large corporate banking division. Two years later, Chris became CEO of NRG, a national recruitment agency, where he worked until joining Quantum.
Commenting on the appointment, Andrew Scaife, Chief Executive Officer of Quantum, said: “We are delighted to welcome Chris to the Board as Chief Financial Officer. Chris has a wealth of relevant experience in management, finance and strategic matters and, having joined the Group last November, a good understanding of the Group’s businesses.
“On behalf of the Board I would like to extend sincere thanks to Martin Such for his significant contribution to the success and growth of the Company during the past eight years and, in particular, to its listing in 2014. We wish him every success going forward.”
Posted by: Quantum Webmaster on 8th March 2016